| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |